Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus (Q63976610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

title

Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

0 references

0 references

0 references

systemic lupus erythematosus

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Nick Geraci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

author name string

Prathyusha Bachali

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Amrie C Grammer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Peter E Lipsky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

language of work or name

English

0 references

publication date

23 April 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

published in

Communications Biology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

issue

1

0 references

page(s)

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

24 April 2020

copyright license

start time

23 April 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

limma

object named as

limma

2 references

22 June 2022

https://europepmc.org/article/PMC/6478921

inferred from PubMed Central ID database lookup

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

WGCNA

object named as

WGCNA

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

GSVA

object named as

GSVA

1 reference

CZ Software Mentions: A large dataset of software mentions in the biomedical literature

cites work

Immune Interferon in the Circulation of Patients with Autoimmune Disease

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Serum interferon levels in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Type I interferon correlates with serological and clinical manifestations of SLE

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Systemic lupus erythematosus: all roads lead to type I interferons

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Possible induction of systemic lupus erythematosus by interferon-α treatment in a patient with a malignant carcinoid tumour

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Severe systemic lupus erythematosus induced by antiviral treatment for hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

High-density nucleosome occupancy map of human chromosome 9p21-22 reveals chromatin organization of the type I interferon gene cluster

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Hyperinducible expression of the interferon-gamma (IFN-gamma) gene and its suppression in systemic lupus erythematosus (SLE).

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cell-activating factor/TNF ligand superfamily-13B

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Interferome v2.0: an updated database of annotated interferon-regulated genes

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Dissecting interferon-induced transcriptional programs in human peripheral blood cells

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

GSVA: gene set variation analysis for microarray and RNA-seq data.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Patterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Interferon and biologic signatures in dermatomyositis skin: specificity and heterogeneity across diseases

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

The role of type I interferons and other cytokines in dermatomyositis

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Induction of interferon-alpha by interferon-beta, but not of interferon-beta by interferon-alpha, in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

PCR-based simultaneous analysis of the interferon-alpha family reveals distinct kinetics for early interferons.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Type 1 interferons and antiviral CD8 T-cell responses

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Cutting Edge: Innate production of IFN-gamma by NK cells is independent of epigenetic modification of the IFN-gamma promoter.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Detection of interferon alpha protein reveals differential levels and cellular sources in disease.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Identification of alterations in macrophage activation associated with disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transitional B Cells.

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

limma powers differential expression analyses for RNA-sequencing and microarray studies

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

WGCNA: an R package for weighted correlation network analysis

1 reference

https://api.crossref.org/works/10.1038%2FS42003-019-0382-X

7 January 2021

Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages

1 reference

12 December 2020

IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice

1 reference

12 December 2020

IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.

1 reference

12 December 2020

Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature

1 reference

12 December 2020

Drug-induced systemic lupus erythematosus in interferon beta-1b therapy

1 reference

12 December 2020

Role of production of type I interferons by B cells in the mechanisms and pathogenesis of systemic lupus erythematosus.

1 reference

12 December 2020

10.1038/S42003-019-0382-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31044165%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

1 reference